Results showed that compared with WT, PAK4 immunoreactivity was significantly lower at early‐sym and late‐sym stages of the disease in ALS mice (Figure 2A and Figure S1A). This evidence concerns the gene PAK4 and amyotrophic lateral sclerosis.